Senior Scientist, Clinical Pharmacolgy

The Senior Scientist, Oncology Therapeutic Area (TA) Clinical Pharmacology (CP) Leader role is to apply and promote Clinical Pharmacology knowledge, including pharmacokinetics/ pharmacodynamics analyses and principles of model-based drug development in the programs for all stages of drug development ranging from pre-New Molecular Entity (NME) declaration through Post-Marketing support, in collaboration with various stakeholders, Quantitative Sciences (QS)-Project Matrix teams and Pharmacometrics (PM) Leader. The Senior Scientist may function as a CP Leader on the Compound Development Team (CDT) and execute the day-to-day operations for the clinical pharmacology aspects of the assigned programs within the Clinical Pharmacology and Pharmacometrics Department.

The Senior Scientist can directly impact the operational results, as they are focused on investigation and characterization of how drugs interact with biological systems or diseases so that they can be used safely and effectively, and with the appropriate pharmaceutical formulation.

 

• Contribute to overall compound development via application of quantitative methods to integrate knowledge of PK, PD, patient characteristics, disease states, and drug-drug interactions to optimize dose selection, dosage regimens and study designs throughout drug development. Working closely with the senior members, the Senior Scientist will translate quantitative knowledge into strategic opportunities with key stake holders to drive development along the model-based drug development principles.
• Collaborate with PM Leaders on modeling and simulation activities in drug development programs. Perform and/or liaise for modeling and simulation analysis of preclinical-clinical data, translational PK/PD data, up to first-in-human (FIH) and if applicable beyond FIH (dose/exposure-response analyses to guide dose regimen from pre-proof of concept (POC) and POC studies).
• Collaborate with PM Leaders on the execution of scientifically robust and efficient clinical pharmacology strategies for NME and/or development candidates.
• Applies the understanding of (1) the impact of intra- and inter-subject variability in physiology and/or pathology, concomitant medication use, and biopharmaceutics, on pharmacokinetics (PK) and PK/pharmacodynamics (PD), and (2) requirements for the clinical pharmacology regulatory submission packages and submission processes.
• Carries out functional responsibilities in accordance to applicable SOPs, regulatory requirements and Johnson & Johnson Credo principles.
• Design and execute PK, PK/PD modeling efforts to address the unique challenges pertinent to the project
• Design Phase I Clinical Pharmacology studies.
• Manage operational elements of Clinical Pharmacology studies.
• Perform literature searches and summarize the findings.
• Contribute in monographs, INDs and other documents as applicable to support clinical studies and regulatory filings (e.g. NDA/BLA).
• Represent Clinical Pharmacology Function in the regulatory meetings (e.g. pre-IND, EoP1, EoP2, NDA/BLA filing etc.) with the assistance of the senior member as appropriate.
• Remain current with clinical and drug development information and methods in modeling and simulation by engaging with the scientific community (e.g., publishing, presenting at meetings, participating in special interest groups within professional societies, etc.) and internalize key learnings back to Janssen.
• Work effectively in matrix environment, managing CP deliverables in accordance with timelines and overall project goals.
• Apply appropriate regulatory (e.g., FDA, EMEA, ICH, etc.) guidelines in the design of clinical development plans and studies.
• Apply relevant technical trainings/learnings to daily responsibilities, with focus of opportunistic deliver of value/impact.